Medicare Enrolled

Dr. Matthew Berger, MD

Psychiatry · Moosic, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
340 MONTAGE MOUNTAIN RD, Moosic, PA 18507
5703463686
In practice since 2005 (20 years)
NPI: 1295718237 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Berger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Berger

Dr. Matthew Berger is a psychiatry specialist in Moosic, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Berger performed 2,139 Medicare services across 789 unique beneficiaries.

Between the years covered by Open Payments, Dr. Berger received a total of $1,624,954 from 46 pharmaceutical and/or device companies across 2613 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Berger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 3% volume in PA $1,624,954 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,139
Medicare services
Top 3% in PA for psychiatry
789
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~107 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
670 $60 $167
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
374 $79 $200
Magnetic field treatment to stimulate brain nerve cells
A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment.
357 $140 $375
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
300 $61 $150
Electrical stimulation therapy
A treatment that uses electrical currents to stimulate nerves or muscles. The specific purpose of the therapy is not defined in the code description.
168 $75 $244
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
74 $37 $154
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
61 $86 $315
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
54 $79 $200
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
40 $47 $150
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
25 $63 $146
Electronic psychological or neuropsychological test administration
Administration of a single standardized psychological or neuropsychological test using an electronic platform that provides automated results.
16 $2 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,624,954
Total received (2018-2024)
Avg $232,136/year across 7 years
Top 0% in PA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
2,613
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,467,638 (90.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$145,132 (8.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,184 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$350,486
2023
$352,109
2022
$220,899
2021
$161,102
2020
$87,069
2019
$186,586
2018
$266,703

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$97,921
Otsuka America Pharmaceutical, Inc.
$89,471
Axsome Therapeutics, Inc.
$51,655
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$31,566
Vanda Pharmaceuticals Inc.
$28,212
Neurocrine Biosciences, Inc.
$18,591
Janssen Pharmaceuticals, Inc
$15,554
Alkermes, Inc.
$12,581
ABBVIE INC.
$4,736
Eisai Inc.
$44
Novo Nordisk Inc
$41
Bausch Health US, LLC
$25
Takeda Pharmaceuticals U.S.A., Inc.
$19
Almatica Pharma LLC
$16
Neuronetics, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$15
Neos Therapeutics, LP
$14
Corium, LLC
$11
Top 3 companies account for 68.2% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$429,309
Neurocrine Biosciences, Inc.
$279,739
Otsuka America Pharmaceutical, Inc.
$240,731
Axsome Therapeutics, Inc.
$140,324
Janssen Pharmaceuticals, Inc
$117,601
ITI, Inc.
$74,561
Alkermes, Inc.
$66,826
Neurocrine BioSciences, Inc.
$38,000
Allergan Inc.
$34,304
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$31,566
Vanda Pharmaceuticals Inc.
$28,343
Eisai Inc.
$27,834
Takeda Pharmaceuticals U.S.A., Inc.
$22,294
Sunovion Pharmaceuticals Inc.
$18,861
IDORSIA PHARMACEUTICALS US INC
$17,700
ABBVIE INC.
$12,173
AbbVie Inc.
$11,634
Sage Therapeutics, Inc.
$9,449
Biogen, Inc.
$4,629
Allergan, Inc.
$4,116
Neuronetics, Inc.
$2,570
ACADIA Pharmaceuticals Inc
$2,513
Avanir Pharmaceuticals, Inc.
$2,307
LivaNova USA, Inc.
$2,198
EISAI INC.
$1,296
BioXcel Therapeutics, Inc.
$1,215
Alfasigma USA, Inc.
$1,076
Bausch Health US, LLC
$296
JAZZ PHARMACEUTICALS INC.
$232
Indivior Inc.
$216
Neos Therapeutics, LP
$152
Lundbeck LLC
$141
Jazz Pharmaceuticals Inc.
$137
Merck Sharp & Dohme Corporation
$129
Novo Nordisk Inc
$100
Merck Sharp & Dohme LLC
$70
Shire North American Group Inc
$69
Almatica Pharma LLC
$55
Harmony Biosciences LLC
$49
Corium, LLC
$38
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
OWP Pharmaceuticals, Inc.
$18
Adlon Therapeutics L.P.
$16
Amgen Inc.
$16
E.R. Squibb & Sons, L.L.C.
$15
Ironshore Pharmaceuticals Inc.
$15
Top 3 companies account for 58.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · ADUHELM · APLENZIN · ARISTADA · AUSTEDO · Aduhelm · Adzenys XR-ODT · Aimovig · Austedo XR · Auvelity · Azstarys · BELSOMRA · CAPLYTA · COTEMPLA XR-ODT · Dayvigo · FANAPT · HETLIOZ · Hetlioz · IGALMI · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · Jornay PM 20mg capsules (Bottle of 100) · KAPSPARGO · LATUDA · LOREEV XR · LYBALVI · Leqembi · MYDAYIS · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · NUPLAZID · Nuedexta · PERSERIS · QUVIVIQ · REXULTI · SERTRALINE HCL · SPRAVATO · SUBLOCADE · SUNOSI · Subvenite · Sunosi · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VIIBRYD · VIVITROL · VNS THERAPY SYMMETRY MODEL 8103 GENERATOR · VRAYLAR · VYVANSE · WELLBUTRIN · WELLBUTRIN XL · Wakix · Wegovy · XYREM · XYWAV · ZULRESSO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for psychiatry in PA.

Looking for a psychiatry specialist in Moosic?
Compare psychiatrists in the Moosic area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
49
Per 100K population
22.7
County median income
$64,691
Nearest hospital
GEISINGER BEHAVIORAL HEALTH CENTER NORTHEAST
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Berger is a clinical cardiology specialist, with above-average Medicare volume (top 3% in PA), with speaking/promotional industry engagement in the top 0% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Berger experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Berger performed 670 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berger receive payments from pharmaceutical companies?
Yes. Dr. Berger received a total of $1,624,954 from 46 companies across 2,613 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berger's costs compare to other psychiatrists in Moosic?
Dr. Berger's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →